Cardiff Oncology, Inc.CRDFNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank57
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-4.95
Near historical average
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-5.07
Historical baseline
PeriodValueYoY Change
2025-4.95+9.6%
2024-5.47-160.6%
2023-2.10-19.5%
2022-1.76+82.6%
2021-10.09+55.6%
2020-22.72-3991.1%
2019-0.56+1.0%
2018-0.56-22.0%
2017-0.46+76.9%
2016-1.99-